CD274 and neoplasm: While monotherapy has achieved little tumor shrinkage, combination regimens—such as DC vaccines with chemotherapy, immune checkpoint inhibitors (anti-PD-1/PD-L1), or cytokine-induced killer cells—have shown greater immune activation and improved survival outcomes [19].